Ondine Biomedical Inc. is a Canadian life sciences company specializing in photodisinfection-based therapies aimed at preventing and treating infections, particularly those caused by drug-resistant pathogens. Their patented platform technology utilizes a photosensitive agent that, when illuminated with non-thermal laser light, generates an oxidative burst capable of destroying a wide range of pathogens, including bacteria, viruses, yeasts, and fungi, within minutes. This rapid action not only eliminates pathogens immediately but also prevents the development of resistance, making it a significant advancement over traditional antibiotics. The technology has demonstrated substantial efficacy in clinical settings, with reports of up to an 84% reduction in postoperative infection rates in major Canadian hospitals.

One of Ondine's flagship products is Steriwave™, a nasal photodisinfection therapy designed to eradicate pathogens in the nasal passages quickly and safely. This treatment is particularly beneficial for high-risk patients, such as those undergoing surgery or with compromised immune systems, as it significantly reduces the risk of healthcare-associated infections (HAIs). Steriwave has been shown to effectively eliminate nasal pathogens, including Staphylococcus aureus and SARS-CoV-2, without generating resistance, thus enhancing patient safety and compliance. The technology is user-friendly and has been integrated into infection control protocols in various healthcare settings, contributing to a marked decrease in surgical site infections and overall healthcare costs.

Canada

Ondine Biomedical is a life sciences company leading the charge in breakthrough photodisinfection-based therapies to prevent and treat serious infections, including those caused by existing, emerging, and antimicrobial-resistant pathogens. The company has created a patented, platform technology (photodisinfection) to provide simple solutions to complex infections across different therapeutic areas in healthcare and industry settings.

Ondine Biomedical

Company Details